Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Fleury

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer|October 18, 2023
Consensus recommendations for improving the cancer clinical trial matching environmentMark E Fleury
JAMA Oncology|June 7, 2019
Reimbursing Patients for Participation in Cancer Clinical TrialsJoseph M Unger, Mark E Fleury
Annual Review of Biomedical Engineering|April 27, 2007
Interstitial flow and its effects in soft tissuesMelody A Swartz, Mark E Fleury
JAMA Oncology|April 1, 2021
Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic Status-ReplyMark E Fleury, Joseph M Unger
JAMA Network Open|July 5, 2022
Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical TrialsDevon V Adams, Sarah Long, Mark E Fleury
JAMA Network Open|August 8, 2025
Views Toward Pharmacogenomic Testing Among Patients With CancerSharon P Shriver, Sarah Long, Mark E Fleury
JAMA Oncology|November 12, 2020
Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical TrialsMark E Fleury, Amy M Farner, Joseph M Unger
Biophysical Journal|April 11, 2006
Autologous morphogen gradients by subtle interstitial flow and matrix interactionsMark E Fleury, Kendrick C Boardman, Melody A Swartz
JAMA|September 12, 2024
State Biomarker Testing Insurance Coverage LawsLisa L Lacasse, Mark E Fleury, Hilary Gee Goeckner
JAMA Network Open|February 25, 2026
The Proposed Drug Conditional Approval Pathway and Responses From Cancer SurvivorsLuke W Chen, Sarah Long, Sharon P Shriver, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer|October 18, 2023
Consensus recommendations for improving the cancer clinical trial matching environmentMark E Fleury
JAMA Oncology|June 7, 2019
Reimbursing Patients for Participation in Cancer Clinical TrialsJoseph M Unger, Mark E Fleury
Annual Review of Biomedical Engineering|April 27, 2007
Interstitial flow and its effects in soft tissuesMelody A Swartz, Mark E Fleury
JAMA Oncology|April 1, 2021
Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic Status-ReplyMark E Fleury, Joseph M Unger
JAMA Network Open|July 5, 2022
Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical TrialsDevon V Adams, Sarah Long, Mark E Fleury
JAMA Network Open|August 8, 2025
Views Toward Pharmacogenomic Testing Among Patients With CancerSharon P Shriver, Sarah Long, Mark E Fleury
JAMA Oncology|November 12, 2020
Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical TrialsMark E Fleury, Amy M Farner, Joseph M Unger
Biophysical Journal|April 11, 2006
Autologous morphogen gradients by subtle interstitial flow and matrix interactionsMark E Fleury, Kendrick C Boardman, Melody A Swartz
JAMA|September 12, 2024
State Biomarker Testing Insurance Coverage LawsLisa L Lacasse, Mark E Fleury, Hilary Gee Goeckner
JAMA Network Open|February 25, 2026
The Proposed Drug Conditional Approval Pathway and Responses From Cancer SurvivorsLuke W Chen, Sarah Long, Sharon P Shriver, et al.
Pageof 3